If you need more lookups,
subscriptions start at $34 USD/month.
Kelly McKee Location
Boston, MA, US
Kelly McKee Work
Vice President, Strategy and Transformation @ (January 2026 - Present)
Head of Innovative Patient Recruitment, Evinova (AstraZeneca Group) @ (April 2024 - October 2025)
Vice President, Decentralized Clinical Trials and Patient Registries @ (October 2022 - April 2024)
Vice President, Patient Registries and Recruitment @ (April 2021 - October 2022)
Senior Director, Patient Recruitment and Registries @ (July 2020 - April 2021)
Head, Patient Recruitment and Patient-Centric Innovations @ (March 2018 - July 2020)
Advisor (Director level), Clinical Innovation @ Eli Lilly and Company (March 2016 - March 2018)
Recruitment, Retention and Innovation Team Leader, Late Stage Development, Global Trial Optimization @ (June 2014 - March 2016)
Associate Director, Global Trial Optimization @ (August 2012 - June 2014)
Manager Global Trial Optimization, TA Lead Infectious Diseases and Vaccines @ (July 2010 - August 2012)
Global Trial Optimization Specialist @ (September 2009 - July 2010)
Clinical Development Liaison @ (January 2008 - September 2009)
Lead CRA @ (August 2004 - January 2007)
Clinical Research Scientist @ (August 2003 - August 2004)
Senior Project Manager @ (August 2000 - August 2003)
Disease Intervention Specialist @ (June 1998 - May 1999)
Kelly McKee Education
Bryn Mawr College
BA (Biology)
1995-1999
University of Nairobi
(Epidemiology)
1998-1998
The George Washington University
Master’s Degree (Clinical Research Administration)
Kelly McKee Skills
CTMS
Clinical Development
Vaccines
Clinical Trials
Infectious Diseases
Biotechnology
Clinical Research
Protocol
CRO
Medicine
Pharmaceutical Industry
Drug Development
Therapeutic Areas
Oncology
Cardiology
Medical Writing
GCP
Clinical Monitoring
Lifesciences
Rheumatology
Neurology
Regulatory Affairs
Endocrinology
Biopharmaceuticals
Diabetes
ICH-GCP
Clinical Data Management
Regulatory Submissions
Medical Affairs
Clinical Study Design
Pharmacovigilance
Life Sciences
CRO Management
Good Clinical Practice (GCP)
Clinical Trial Management System (CTMS)
Kelly McKee Summary
Kelly McKee, based in Boston, MA, US, is currently a Vice President, Strategy and Transformation at Science 37. Kelly McKee brings experience from previous roles at AstraZeneca and Medidata Solutions. Kelly McKee holds a 1995 - 1999 BA in Biology @ Bryn Mawr College. With a robust skill set that includes CTMS, Clinical Development, Vaccines, Clinical Trials, Infectious Diseases and more. Kelly McKee has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Kelly McKee?
Find contact details for 700 million professionals.